Further subgroup analysis showed that with increased serum ferritin levels, participants in the NAFLD group displayed more severe metabolic dysregulation (BMI, WC, TG, creatinine, glucose, insulin, HOMR-IR increased) and liver function abnormality (ALT, AST, and GGT increased). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.